nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfentanil—ABCB1—kidney cancer	0.2	1	CbGaD
Alfentanil—CYP3A7—Temsirolimus—kidney cancer	0.061	0.0898	CbGbCtD
Alfentanil—CYP3A7-CYP3A51P—Temsirolimus—kidney cancer	0.061	0.0898	CbGbCtD
Alfentanil—ORM1—Erlotinib—kidney cancer	0.0507	0.0747	CbGbCtD
Alfentanil—CYP3A5—Temsirolimus—kidney cancer	0.0457	0.0674	CbGbCtD
Alfentanil—ABCB1—Temsirolimus—kidney cancer	0.0298	0.0439	CbGbCtD
Alfentanil—CYP3A4—Everolimus—kidney cancer	0.0264	0.0389	CbGbCtD
Alfentanil—ALB—Erlotinib—kidney cancer	0.0213	0.0314	CbGbCtD
Alfentanil—CYP3A7—Paclitaxel—kidney cancer	0.0209	0.0308	CbGbCtD
Alfentanil—CYP3A7-CYP3A51P—Paclitaxel—kidney cancer	0.0209	0.0308	CbGbCtD
Alfentanil—CYP3A7—Sorafenib—kidney cancer	0.0186	0.0274	CbGbCtD
Alfentanil—CYP3A7-CYP3A51P—Sorafenib—kidney cancer	0.0186	0.0274	CbGbCtD
Alfentanil—CYP3A7-CYP3A51P—Vincristine—kidney cancer	0.018	0.0266	CbGbCtD
Alfentanil—CYP3A7—Vincristine—kidney cancer	0.018	0.0266	CbGbCtD
Alfentanil—CYP3A4—Temsirolimus—kidney cancer	0.0178	0.0263	CbGbCtD
Alfentanil—CYP3A5—Erlotinib—kidney cancer	0.0171	0.0253	CbGbCtD
Alfentanil—CYP3A5—Paclitaxel—kidney cancer	0.0157	0.0231	CbGbCtD
Alfentanil—ABCB1—Pazopanib—kidney cancer	0.0156	0.023	CbGbCtD
Alfentanil—CYP3A7—Sunitinib—kidney cancer	0.0151	0.0222	CbGbCtD
Alfentanil—CYP3A7-CYP3A51P—Sunitinib—kidney cancer	0.0151	0.0222	CbGbCtD
Alfentanil—ABCB1—Dactinomycin—kidney cancer	0.0143	0.0211	CbGbCtD
Alfentanil—CYP3A5—Sorafenib—kidney cancer	0.0139	0.0205	CbGbCtD
Alfentanil—CYP3A5—Vincristine—kidney cancer	0.0135	0.0199	CbGbCtD
Alfentanil—ABCB1—Gemcitabine—kidney cancer	0.0113	0.0167	CbGbCtD
Alfentanil—CYP3A5—Sunitinib—kidney cancer	0.0113	0.0166	CbGbCtD
Alfentanil—ABCB1—Erlotinib—kidney cancer	0.0112	0.0164	CbGbCtD
Alfentanil—ABCB1—Paclitaxel—kidney cancer	0.0102	0.015	CbGbCtD
Alfentanil—CYP3A4—Pazopanib—kidney cancer	0.00937	0.0138	CbGbCtD
Alfentanil—ABCB1—Sorafenib—kidney cancer	0.00907	0.0134	CbGbCtD
Alfentanil—ABCB1—Vinblastine—kidney cancer	0.00896	0.0132	CbGbCtD
Alfentanil—ABCB1—Vincristine—kidney cancer	0.0088	0.013	CbGbCtD
Alfentanil—ABCB1—Sunitinib—kidney cancer	0.00735	0.0108	CbGbCtD
Alfentanil—CYP3A4—Erlotinib—kidney cancer	0.00668	0.00985	CbGbCtD
Alfentanil—CYP3A4—Paclitaxel—kidney cancer	0.00612	0.00902	CbGbCtD
Alfentanil—ABCB1—Doxorubicin—kidney cancer	0.0055	0.00811	CbGbCtD
Alfentanil—CYP3A4—Sorafenib—kidney cancer	0.00543	0.00801	CbGbCtD
Alfentanil—CYP3A4—Vinblastine—kidney cancer	0.00537	0.00791	CbGbCtD
Alfentanil—CYP3A4—Vincristine—kidney cancer	0.00528	0.00777	CbGbCtD
Alfentanil—CYP3A4—Sunitinib—kidney cancer	0.0044	0.00649	CbGbCtD
Alfentanil—CYP3A4—Doxorubicin—kidney cancer	0.0033	0.00486	CbGbCtD
Alfentanil—Chills—Gemcitabine—kidney cancer	0.000278	0.00235	CcSEcCtD
Alfentanil—Skin disorder—Sorafenib—kidney cancer	0.000277	0.00234	CcSEcCtD
Alfentanil—Arrhythmia—Gemcitabine—kidney cancer	0.000277	0.00234	CcSEcCtD
Alfentanil—Headache—Temsirolimus—kidney cancer	0.000276	0.00234	CcSEcCtD
Alfentanil—Dizziness—Pazopanib—kidney cancer	0.000275	0.00233	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Erlotinib—kidney cancer	0.000273	0.00232	CcSEcCtD
Alfentanil—Hiccups—Doxorubicin—kidney cancer	0.000273	0.00231	CcSEcCtD
Alfentanil—Fatigue—Erlotinib—kidney cancer	0.000273	0.00231	CcSEcCtD
Alfentanil—Epistaxis—Paclitaxel—kidney cancer	0.000272	0.00231	CcSEcCtD
Alfentanil—Feeling abnormal—Vinblastine—kidney cancer	0.000271	0.0023	CcSEcCtD
Alfentanil—Pain—Erlotinib—kidney cancer	0.000271	0.00229	CcSEcCtD
Alfentanil—Feeling abnormal—Everolimus—kidney cancer	0.00027	0.00229	CcSEcCtD
Alfentanil—Erythema—Gemcitabine—kidney cancer	0.000269	0.00228	CcSEcCtD
Alfentanil—Nervous system disorder—Sunitinib—kidney cancer	0.000269	0.00228	CcSEcCtD
Alfentanil—Skin disorder—Sunitinib—kidney cancer	0.000266	0.00226	CcSEcCtD
Alfentanil—Vomiting—Pazopanib—kidney cancer	0.000264	0.00224	CcSEcCtD
Alfentanil—Bradycardia—Paclitaxel—kidney cancer	0.000264	0.00224	CcSEcCtD
Alfentanil—Rash—Pazopanib—kidney cancer	0.000262	0.00222	CcSEcCtD
Alfentanil—Nausea—Temsirolimus—kidney cancer	0.000262	0.00222	CcSEcCtD
Alfentanil—Dermatitis—Pazopanib—kidney cancer	0.000262	0.00222	CcSEcCtD
Alfentanil—Bronchospasm—Capecitabine—kidney cancer	0.000261	0.00222	CcSEcCtD
Alfentanil—Agitation—Vincristine—kidney cancer	0.000261	0.00221	CcSEcCtD
Alfentanil—Headache—Pazopanib—kidney cancer	0.00026	0.00221	CcSEcCtD
Alfentanil—Body temperature increased—Everolimus—kidney cancer	0.000259	0.0022	CcSEcCtD
Alfentanil—Connective tissue disorder—Paclitaxel—kidney cancer	0.000255	0.00216	CcSEcCtD
Alfentanil—Body temperature increased—Erlotinib—kidney cancer	0.00025	0.00212	CcSEcCtD
Alfentanil—Visual impairment—Paclitaxel—kidney cancer	0.00025	0.00212	CcSEcCtD
Alfentanil—Nausea—Pazopanib—kidney cancer	0.000247	0.00209	CcSEcCtD
Alfentanil—Convulsion—Vincristine—kidney cancer	0.000246	0.00209	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000246	0.00208	CcSEcCtD
Alfentanil—Fatigue—Sorafenib—kidney cancer	0.000246	0.00208	CcSEcCtD
Alfentanil—Hypertension—Vincristine—kidney cancer	0.000245	0.00208	CcSEcCtD
Alfentanil—Pain—Sorafenib—kidney cancer	0.000244	0.00206	CcSEcCtD
Alfentanil—Hypersensitivity—Vinblastine—kidney cancer	0.000243	0.00206	CcSEcCtD
Alfentanil—Eye disorder—Paclitaxel—kidney cancer	0.000242	0.00205	CcSEcCtD
Alfentanil—Hypersensitivity—Everolimus—kidney cancer	0.000242	0.00205	CcSEcCtD
Alfentanil—Cardiac disorder—Paclitaxel—kidney cancer	0.000241	0.00204	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000237	0.00201	CcSEcCtD
Alfentanil—Asthenia—Vinblastine—kidney cancer	0.000236	0.002	CcSEcCtD
Alfentanil—Fatigue—Sunitinib—kidney cancer	0.000236	0.002	CcSEcCtD
Alfentanil—Asthenia—Everolimus—kidney cancer	0.000235	0.002	CcSEcCtD
Alfentanil—Cough—Gemcitabine—kidney cancer	0.000235	0.00199	CcSEcCtD
Alfentanil—Angiopathy—Paclitaxel—kidney cancer	0.000235	0.00199	CcSEcCtD
Alfentanil—Pain—Sunitinib—kidney cancer	0.000234	0.00199	CcSEcCtD
Alfentanil—Immune system disorder—Paclitaxel—kidney cancer	0.000234	0.00198	CcSEcCtD
Alfentanil—Mediastinal disorder—Paclitaxel—kidney cancer	0.000234	0.00198	CcSEcCtD
Alfentanil—Hypertension—Gemcitabine—kidney cancer	0.000233	0.00197	CcSEcCtD
Alfentanil—Chills—Paclitaxel—kidney cancer	0.000233	0.00197	CcSEcCtD
Alfentanil—Pruritus—Everolimus—kidney cancer	0.000232	0.00197	CcSEcCtD
Alfentanil—Anaphylactic shock—Vincristine—kidney cancer	0.000232	0.00196	CcSEcCtD
Alfentanil—Arrhythmia—Paclitaxel—kidney cancer	0.000232	0.00196	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.000228	0.00193	CcSEcCtD
Alfentanil—Nervous system disorder—Vincristine—kidney cancer	0.000227	0.00193	CcSEcCtD
Alfentanil—Asthenia—Erlotinib—kidney cancer	0.000227	0.00193	CcSEcCtD
Alfentanil—Mental disorder—Paclitaxel—kidney cancer	0.000227	0.00192	CcSEcCtD
Alfentanil—Urticaria—Sorafenib—kidney cancer	0.000226	0.00192	CcSEcCtD
Alfentanil—Erythema—Paclitaxel—kidney cancer	0.000226	0.00191	CcSEcCtD
Alfentanil—Body temperature increased—Sorafenib—kidney cancer	0.000225	0.00191	CcSEcCtD
Alfentanil—Hyperhidrosis—Vincristine—kidney cancer	0.000224	0.0019	CcSEcCtD
Alfentanil—Pruritus—Erlotinib—kidney cancer	0.000224	0.0019	CcSEcCtD
Alfentanil—Fatigue—Dactinomycin—kidney cancer	0.000224	0.0019	CcSEcCtD
Alfentanil—Epistaxis—Capecitabine—kidney cancer	0.000223	0.00189	CcSEcCtD
Alfentanil—Pain—Dactinomycin—kidney cancer	0.000222	0.00188	CcSEcCtD
Alfentanil—Anaphylactic shock—Gemcitabine—kidney cancer	0.00022	0.00186	CcSEcCtD
Alfentanil—Dizziness—Vinblastine—kidney cancer	0.000218	0.00185	CcSEcCtD
Alfentanil—Dizziness—Everolimus—kidney cancer	0.000217	0.00184	CcSEcCtD
Alfentanil—Body temperature increased—Sunitinib—kidney cancer	0.000217	0.00184	CcSEcCtD
Alfentanil—Hypotension—Vincristine—kidney cancer	0.000217	0.00184	CcSEcCtD
Alfentanil—Bradycardia—Capecitabine—kidney cancer	0.000217	0.00183	CcSEcCtD
Alfentanil—Nervous system disorder—Gemcitabine—kidney cancer	0.000216	0.00183	CcSEcCtD
Alfentanil—Feeling abnormal—Dactinomycin—kidney cancer	0.000214	0.00181	CcSEcCtD
Alfentanil—Skin disorder—Gemcitabine—kidney cancer	0.000214	0.00181	CcSEcCtD
Alfentanil—Vision blurred—Paclitaxel—kidney cancer	0.000213	0.0018	CcSEcCtD
Alfentanil—Hyperhidrosis—Gemcitabine—kidney cancer	0.000213	0.0018	CcSEcCtD
Alfentanil—Hypersensitivity—Sorafenib—kidney cancer	0.00021	0.00178	CcSEcCtD
Alfentanil—Vomiting—Vinblastine—kidney cancer	0.000209	0.00177	CcSEcCtD
Alfentanil—Dizziness—Erlotinib—kidney cancer	0.000209	0.00177	CcSEcCtD
Alfentanil—Connective tissue disorder—Capecitabine—kidney cancer	0.000209	0.00177	CcSEcCtD
Alfentanil—Vomiting—Everolimus—kidney cancer	0.000209	0.00177	CcSEcCtD
Alfentanil—Agitation—Paclitaxel—kidney cancer	0.000207	0.00176	CcSEcCtD
Alfentanil—Rash—Everolimus—kidney cancer	0.000207	0.00175	CcSEcCtD
Alfentanil—Dermatitis—Everolimus—kidney cancer	0.000207	0.00175	CcSEcCtD
Alfentanil—Headache—Vinblastine—kidney cancer	0.000206	0.00175	CcSEcCtD
Alfentanil—Headache—Everolimus—kidney cancer	0.000206	0.00174	CcSEcCtD
Alfentanil—Hypotension—Gemcitabine—kidney cancer	0.000205	0.00174	CcSEcCtD
Alfentanil—Body temperature increased—Dactinomycin—kidney cancer	0.000205	0.00174	CcSEcCtD
Alfentanil—Visual impairment—Capecitabine—kidney cancer	0.000205	0.00174	CcSEcCtD
Alfentanil—Anaphylactoid reaction—Doxorubicin—kidney cancer	0.000205	0.00174	CcSEcCtD
Alfentanil—Asthenia—Sorafenib—kidney cancer	0.000204	0.00173	CcSEcCtD
Alfentanil—Hypersensitivity—Sunitinib—kidney cancer	0.000202	0.00171	CcSEcCtD
Alfentanil—Pruritus—Sorafenib—kidney cancer	0.000202	0.00171	CcSEcCtD
Alfentanil—Vomiting—Erlotinib—kidney cancer	0.000201	0.00171	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Vincristine—kidney cancer	0.0002	0.0017	CcSEcCtD
Alfentanil—Fatigue—Vincristine—kidney cancer	0.0002	0.00169	CcSEcCtD
Alfentanil—Rash—Erlotinib—kidney cancer	0.0002	0.00169	CcSEcCtD
Alfentanil—Dermatitis—Erlotinib—kidney cancer	0.000199	0.00169	CcSEcCtD
Alfentanil—Eye disorder—Capecitabine—kidney cancer	0.000199	0.00168	CcSEcCtD
Alfentanil—Headache—Erlotinib—kidney cancer	0.000198	0.00168	CcSEcCtD
Alfentanil—Loss of consciousness—Paclitaxel—kidney cancer	0.000198	0.00168	CcSEcCtD
Alfentanil—Pain—Vincristine—kidney cancer	0.000198	0.00168	CcSEcCtD
Alfentanil—Cardiac disorder—Capecitabine—kidney cancer	0.000197	0.00167	CcSEcCtD
Alfentanil—Cough—Paclitaxel—kidney cancer	0.000197	0.00167	CcSEcCtD
Alfentanil—Asthenia—Sunitinib—kidney cancer	0.000197	0.00167	CcSEcCtD
Alfentanil—Nausea—Vinblastine—kidney cancer	0.000196	0.00166	CcSEcCtD
Alfentanil—Somnolence—Gemcitabine—kidney cancer	0.000195	0.00166	CcSEcCtD
Alfentanil—Convulsion—Paclitaxel—kidney cancer	0.000195	0.00166	CcSEcCtD
Alfentanil—Nausea—Everolimus—kidney cancer	0.000195	0.00165	CcSEcCtD
Alfentanil—Hypertension—Paclitaxel—kidney cancer	0.000195	0.00165	CcSEcCtD
Alfentanil—Pruritus—Sunitinib—kidney cancer	0.000194	0.00164	CcSEcCtD
Alfentanil—Angiopathy—Capecitabine—kidney cancer	0.000193	0.00164	CcSEcCtD
Alfentanil—Immune system disorder—Capecitabine—kidney cancer	0.000192	0.00163	CcSEcCtD
Alfentanil—Mediastinal disorder—Capecitabine—kidney cancer	0.000192	0.00162	CcSEcCtD
Alfentanil—Hypersensitivity—Dactinomycin—kidney cancer	0.000191	0.00162	CcSEcCtD
Alfentanil—Chills—Capecitabine—kidney cancer	0.000191	0.00162	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000191	0.00162	CcSEcCtD
Alfentanil—Arrhythmia—Capecitabine—kidney cancer	0.00019	0.00161	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.00019	0.00161	CcSEcCtD
Alfentanil—Fatigue—Gemcitabine—kidney cancer	0.00019	0.00161	CcSEcCtD
Alfentanil—Cardiac arrest—Doxorubicin—kidney cancer	0.000188	0.0016	CcSEcCtD
Alfentanil—Dizziness—Sorafenib—kidney cancer	0.000188	0.0016	CcSEcCtD
Alfentanil—Pain—Gemcitabine—kidney cancer	0.000188	0.00159	CcSEcCtD
Alfentanil—Nausea—Erlotinib—kidney cancer	0.000188	0.00159	CcSEcCtD
Alfentanil—Mental disorder—Capecitabine—kidney cancer	0.000186	0.00158	CcSEcCtD
Alfentanil—Asthenia—Dactinomycin—kidney cancer	0.000186	0.00158	CcSEcCtD
Alfentanil—Confusional state—Paclitaxel—kidney cancer	0.000186	0.00157	CcSEcCtD
Alfentanil—Erythema—Capecitabine—kidney cancer	0.000185	0.00157	CcSEcCtD
Alfentanil—Anaphylactic shock—Paclitaxel—kidney cancer	0.000184	0.00156	CcSEcCtD
Alfentanil—Body temperature increased—Vincristine—kidney cancer	0.000183	0.00155	CcSEcCtD
Alfentanil—Dizziness—Sunitinib—kidney cancer	0.000181	0.00154	CcSEcCtD
Alfentanil—Feeling abnormal—Gemcitabine—kidney cancer	0.000181	0.00154	CcSEcCtD
Alfentanil—Vomiting—Sorafenib—kidney cancer	0.000181	0.00153	CcSEcCtD
Alfentanil—Nervous system disorder—Paclitaxel—kidney cancer	0.000181	0.00153	CcSEcCtD
Alfentanil—Tachycardia—Paclitaxel—kidney cancer	0.00018	0.00152	CcSEcCtD
Alfentanil—Rash—Sorafenib—kidney cancer	0.00018	0.00152	CcSEcCtD
Alfentanil—Dermatitis—Sorafenib—kidney cancer	0.000179	0.00152	CcSEcCtD
Alfentanil—Skin disorder—Paclitaxel—kidney cancer	0.000179	0.00152	CcSEcCtD
Alfentanil—Headache—Sorafenib—kidney cancer	0.000178	0.00151	CcSEcCtD
Alfentanil—Hyperhidrosis—Paclitaxel—kidney cancer	0.000178	0.00151	CcSEcCtD
Alfentanil—Vision blurred—Capecitabine—kidney cancer	0.000174	0.00148	CcSEcCtD
Alfentanil—Vomiting—Sunitinib—kidney cancer	0.000174	0.00148	CcSEcCtD
Alfentanil—Body temperature increased—Gemcitabine—kidney cancer	0.000174	0.00147	CcSEcCtD
Alfentanil—Rash—Sunitinib—kidney cancer	0.000173	0.00146	CcSEcCtD
Alfentanil—Dermatitis—Sunitinib—kidney cancer	0.000173	0.00146	CcSEcCtD
Alfentanil—Hypotension—Paclitaxel—kidney cancer	0.000172	0.00146	CcSEcCtD
Alfentanil—Headache—Sunitinib—kidney cancer	0.000172	0.00146	CcSEcCtD
Alfentanil—Hypersensitivity—Vincristine—kidney cancer	0.000171	0.00145	CcSEcCtD
Alfentanil—Nausea—Sorafenib—kidney cancer	0.000169	0.00143	CcSEcCtD
Alfentanil—Asthenia—Vincristine—kidney cancer	0.000166	0.00141	CcSEcCtD
Alfentanil—Vomiting—Dactinomycin—kidney cancer	0.000165	0.0014	CcSEcCtD
Alfentanil—Somnolence—Paclitaxel—kidney cancer	0.000164	0.00139	CcSEcCtD
Alfentanil—Rash—Dactinomycin—kidney cancer	0.000164	0.00139	CcSEcCtD
Alfentanil—Nausea—Sunitinib—kidney cancer	0.000163	0.00138	CcSEcCtD
Alfentanil—Loss of consciousness—Capecitabine—kidney cancer	0.000163	0.00138	CcSEcCtD
Alfentanil—Cough—Capecitabine—kidney cancer	0.000162	0.00137	CcSEcCtD
Alfentanil—Hypertension—Capecitabine—kidney cancer	0.00016	0.00135	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000159	0.00135	CcSEcCtD
Alfentanil—Fatigue—Paclitaxel—kidney cancer	0.000159	0.00135	CcSEcCtD
Alfentanil—Asthenia—Gemcitabine—kidney cancer	0.000158	0.00134	CcSEcCtD
Alfentanil—Pain—Paclitaxel—kidney cancer	0.000157	0.00133	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000157	0.00133	CcSEcCtD
Alfentanil—Pruritus—Gemcitabine—kidney cancer	0.000156	0.00132	CcSEcCtD
Alfentanil—Nausea—Dactinomycin—kidney cancer	0.000154	0.00131	CcSEcCtD
Alfentanil—Dizziness—Vincristine—kidney cancer	0.000153	0.0013	CcSEcCtD
Alfentanil—Drowsiness—Doxorubicin—kidney cancer	0.000153	0.00129	CcSEcCtD
Alfentanil—Confusional state—Capecitabine—kidney cancer	0.000152	0.00129	CcSEcCtD
Alfentanil—Feeling abnormal—Paclitaxel—kidney cancer	0.000152	0.00129	CcSEcCtD
Alfentanil—Nervous system disorder—Capecitabine—kidney cancer	0.000148	0.00126	CcSEcCtD
Alfentanil—Tachycardia—Capecitabine—kidney cancer	0.000147	0.00125	CcSEcCtD
Alfentanil—Vomiting—Vincristine—kidney cancer	0.000147	0.00125	CcSEcCtD
Alfentanil—Skin disorder—Capecitabine—kidney cancer	0.000147	0.00124	CcSEcCtD
Alfentanil—Urticaria—Paclitaxel—kidney cancer	0.000146	0.00124	CcSEcCtD
Alfentanil—Rash—Vincristine—kidney cancer	0.000146	0.00124	CcSEcCtD
Alfentanil—Hyperhidrosis—Capecitabine—kidney cancer	0.000146	0.00124	CcSEcCtD
Alfentanil—Dermatitis—Vincristine—kidney cancer	0.000146	0.00124	CcSEcCtD
Alfentanil—Body temperature increased—Paclitaxel—kidney cancer	0.000146	0.00123	CcSEcCtD
Alfentanil—Headache—Vincristine—kidney cancer	0.000145	0.00123	CcSEcCtD
Alfentanil—Epistaxis—Doxorubicin—kidney cancer	0.000144	0.00122	CcSEcCtD
Alfentanil—Hypotension—Capecitabine—kidney cancer	0.000141	0.0012	CcSEcCtD
Alfentanil—Vomiting—Gemcitabine—kidney cancer	0.00014	0.00119	CcSEcCtD
Alfentanil—Bradycardia—Doxorubicin—kidney cancer	0.00014	0.00118	CcSEcCtD
Alfentanil—Rash—Gemcitabine—kidney cancer	0.000139	0.00118	CcSEcCtD
Alfentanil—Dermatitis—Gemcitabine—kidney cancer	0.000139	0.00117	CcSEcCtD
Alfentanil—Headache—Gemcitabine—kidney cancer	0.000138	0.00117	CcSEcCtD
Alfentanil—Nausea—Vincristine—kidney cancer	0.000138	0.00117	CcSEcCtD
Alfentanil—Hypersensitivity—Paclitaxel—kidney cancer	0.000136	0.00115	CcSEcCtD
Alfentanil—Connective tissue disorder—Doxorubicin—kidney cancer	0.000135	0.00114	CcSEcCtD
Alfentanil—Visual impairment—Doxorubicin—kidney cancer	0.000132	0.00112	CcSEcCtD
Alfentanil—Asthenia—Paclitaxel—kidney cancer	0.000132	0.00112	CcSEcCtD
Alfentanil—Nausea—Gemcitabine—kidney cancer	0.000131	0.00111	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Capecitabine—kidney cancer	0.00013	0.00111	CcSEcCtD
Alfentanil—Fatigue—Capecitabine—kidney cancer	0.00013	0.0011	CcSEcCtD
Alfentanil—Pruritus—Paclitaxel—kidney cancer	0.00013	0.0011	CcSEcCtD
Alfentanil—Pain—Capecitabine—kidney cancer	0.000129	0.0011	CcSEcCtD
Alfentanil—Eye disorder—Doxorubicin—kidney cancer	0.000128	0.00109	CcSEcCtD
Alfentanil—Cardiac disorder—Doxorubicin—kidney cancer	0.000127	0.00108	CcSEcCtD
Alfentanil—Feeling abnormal—Capecitabine—kidney cancer	0.000125	0.00106	CcSEcCtD
Alfentanil—Angiopathy—Doxorubicin—kidney cancer	0.000124	0.00105	CcSEcCtD
Alfentanil—Immune system disorder—Doxorubicin—kidney cancer	0.000124	0.00105	CcSEcCtD
Alfentanil—Mediastinal disorder—Doxorubicin—kidney cancer	0.000124	0.00105	CcSEcCtD
Alfentanil—Chills—Doxorubicin—kidney cancer	0.000123	0.00104	CcSEcCtD
Alfentanil—Arrhythmia—Doxorubicin—kidney cancer	0.000122	0.00104	CcSEcCtD
Alfentanil—Dizziness—Paclitaxel—kidney cancer	0.000122	0.00103	CcSEcCtD
Alfentanil—Mental disorder—Doxorubicin—kidney cancer	0.00012	0.00102	CcSEcCtD
Alfentanil—Urticaria—Capecitabine—kidney cancer	0.00012	0.00102	CcSEcCtD
Alfentanil—Body temperature increased—Capecitabine—kidney cancer	0.000119	0.00101	CcSEcCtD
Alfentanil—Erythema—Doxorubicin—kidney cancer	0.000119	0.00101	CcSEcCtD
Alfentanil—Vomiting—Paclitaxel—kidney cancer	0.000117	0.000992	CcSEcCtD
Alfentanil—Rash—Paclitaxel—kidney cancer	0.000116	0.000984	CcSEcCtD
Alfentanil—Dermatitis—Paclitaxel—kidney cancer	0.000116	0.000983	CcSEcCtD
Alfentanil—Headache—Paclitaxel—kidney cancer	0.000115	0.000978	CcSEcCtD
Alfentanil—Vision blurred—Doxorubicin—kidney cancer	0.000112	0.000953	CcSEcCtD
Alfentanil—Hypersensitivity—Capecitabine—kidney cancer	0.000111	0.000943	CcSEcCtD
Alfentanil—Agitation—Doxorubicin—kidney cancer	0.00011	0.000929	CcSEcCtD
Alfentanil—Nausea—Paclitaxel—kidney cancer	0.000109	0.000927	CcSEcCtD
Alfentanil—Asthenia—Capecitabine—kidney cancer	0.000108	0.000919	CcSEcCtD
Alfentanil—Pruritus—Capecitabine—kidney cancer	0.000107	0.000906	CcSEcCtD
Alfentanil—Loss of consciousness—Doxorubicin—kidney cancer	0.000105	0.000889	CcSEcCtD
Alfentanil—Cough—Doxorubicin—kidney cancer	0.000104	0.000883	CcSEcCtD
Alfentanil—Convulsion—Doxorubicin—kidney cancer	0.000103	0.000876	CcSEcCtD
Alfentanil—Hypertension—Doxorubicin—kidney cancer	0.000103	0.000873	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000101	0.000855	CcSEcCtD
Alfentanil—Dizziness—Capecitabine—kidney cancer	9.99e-05	0.000847	CcSEcCtD
Alfentanil—Confusional state—Doxorubicin—kidney cancer	9.82e-05	0.000832	CcSEcCtD
Alfentanil—Anaphylactic shock—Doxorubicin—kidney cancer	9.74e-05	0.000825	CcSEcCtD
Alfentanil—Vomiting—Capecitabine—kidney cancer	9.61e-05	0.000814	CcSEcCtD
Alfentanil—Nervous system disorder—Doxorubicin—kidney cancer	9.55e-05	0.00081	CcSEcCtD
Alfentanil—Rash—Capecitabine—kidney cancer	9.53e-05	0.000807	CcSEcCtD
Alfentanil—Dermatitis—Capecitabine—kidney cancer	9.52e-05	0.000807	CcSEcCtD
Alfentanil—Tachycardia—Doxorubicin—kidney cancer	9.51e-05	0.000806	CcSEcCtD
Alfentanil—Headache—Capecitabine—kidney cancer	9.47e-05	0.000802	CcSEcCtD
Alfentanil—Skin disorder—Doxorubicin—kidney cancer	9.46e-05	0.000802	CcSEcCtD
Alfentanil—Hyperhidrosis—Doxorubicin—kidney cancer	9.42e-05	0.000798	CcSEcCtD
Alfentanil—Hypotension—Doxorubicin—kidney cancer	9.1e-05	0.000771	CcSEcCtD
Alfentanil—Nausea—Capecitabine—kidney cancer	8.97e-05	0.000761	CcSEcCtD
Alfentanil—Somnolence—Doxorubicin—kidney cancer	8.66e-05	0.000734	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Doxorubicin—kidney cancer	8.41e-05	0.000713	CcSEcCtD
Alfentanil—Fatigue—Doxorubicin—kidney cancer	8.4e-05	0.000712	CcSEcCtD
Alfentanil—Pain—Doxorubicin—kidney cancer	8.33e-05	0.000706	CcSEcCtD
Alfentanil—Feeling abnormal—Doxorubicin—kidney cancer	8.03e-05	0.00068	CcSEcCtD
Alfentanil—Urticaria—Doxorubicin—kidney cancer	7.74e-05	0.000656	CcSEcCtD
Alfentanil—Body temperature increased—Doxorubicin—kidney cancer	7.7e-05	0.000653	CcSEcCtD
Alfentanil—Hypersensitivity—Doxorubicin—kidney cancer	7.18e-05	0.000608	CcSEcCtD
Alfentanil—Asthenia—Doxorubicin—kidney cancer	6.99e-05	0.000592	CcSEcCtD
Alfentanil—Pruritus—Doxorubicin—kidney cancer	6.89e-05	0.000584	CcSEcCtD
Alfentanil—Dizziness—Doxorubicin—kidney cancer	6.44e-05	0.000546	CcSEcCtD
Alfentanil—Vomiting—Doxorubicin—kidney cancer	6.19e-05	0.000525	CcSEcCtD
Alfentanil—Rash—Doxorubicin—kidney cancer	6.14e-05	0.00052	CcSEcCtD
Alfentanil—Dermatitis—Doxorubicin—kidney cancer	6.14e-05	0.00052	CcSEcCtD
Alfentanil—Headache—Doxorubicin—kidney cancer	6.1e-05	0.000517	CcSEcCtD
Alfentanil—Nausea—Doxorubicin—kidney cancer	5.79e-05	0.00049	CcSEcCtD
Alfentanil—OPRM1—GPCR ligand binding—POMC—kidney cancer	3.95e-06	0.00107	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PDHB—kidney cancer	3.95e-06	0.00107	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	3.83e-06	0.00103	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	3.8e-06	0.00103	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—CA9—kidney cancer	3.8e-06	0.00103	CbGpPWpGaD
Alfentanil—CYP3A4—Biological oxidations—GSTP1—kidney cancer	3.73e-06	0.00101	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—GPC3—kidney cancer	3.73e-06	0.00101	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CCBL1—kidney cancer	3.71e-06	0.001	CbGpPWpGaD
Alfentanil—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	3.68e-06	0.000995	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GLIPR1—kidney cancer	3.67e-06	0.000992	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PPAT—kidney cancer	3.67e-06	0.000992	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	3.62e-06	0.00098	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CA2—kidney cancer	3.62e-06	0.00098	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	3.59e-06	0.00097	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—ALAD—kidney cancer	3.53e-06	0.000955	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—ST3GAL2—kidney cancer	3.45e-06	0.000932	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—AKAP13—kidney cancer	3.43e-06	0.000928	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CASP2—kidney cancer	3.43e-06	0.000928	CbGpPWpGaD
Alfentanil—CYP3A4—Biological oxidations—GSTM1—kidney cancer	3.43e-06	0.000927	CbGpPWpGaD
Alfentanil—ALB—Metabolism—APRT—kidney cancer	3.41e-06	0.000922	CbGpPWpGaD
Alfentanil—ALB—Metabolism—FH—kidney cancer	3.41e-06	0.000922	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—IFNA1—kidney cancer	3.38e-06	0.000915	CbGpPWpGaD
Alfentanil—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	3.38e-06	0.000914	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—ALDH1A1—kidney cancer	3.37e-06	0.000911	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	3.34e-06	0.000902	CbGpPWpGaD
Alfentanil—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	3.25e-06	0.000879	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—CRABP1—kidney cancer	3.23e-06	0.000873	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—SLC5A3—kidney cancer	3.23e-06	0.000873	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PGK1—kidney cancer	3.23e-06	0.000873	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PPAT—kidney cancer	3.22e-06	0.000869	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GLIPR1—kidney cancer	3.22e-06	0.000869	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GPC3—kidney cancer	3.21e-06	0.000867	CbGpPWpGaD
Alfentanil—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	3.21e-06	0.000866	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—LDHB—kidney cancer	3.17e-06	0.000856	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—IFNA2—kidney cancer	3.15e-06	0.000852	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—GRB7—kidney cancer	3.14e-06	0.000849	CbGpPWpGaD
Alfentanil—ALB—Transmembrane transport of small molecules—SLC5A5—kidney cancer	3.13e-06	0.000847	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CA2—kidney cancer	3.12e-06	0.000844	CbGpPWpGaD
Alfentanil—ALB—Metabolism—ALAD—kidney cancer	3.04e-06	0.000822	CbGpPWpGaD
Alfentanil—ALB—Platelet activation, signaling and aggregation—RAF1—kidney cancer	3.03e-06	0.000819	CbGpPWpGaD
Alfentanil—ALB—Transmembrane transport of small molecules—SLC2A1—kidney cancer	3.03e-06	0.000818	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—ITPR2—kidney cancer	3e-06	0.000812	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—APRT—kidney cancer	2.99e-06	0.000808	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—FH—kidney cancer	2.99e-06	0.000808	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	2.98e-06	0.000806	CbGpPWpGaD
Alfentanil—ALB—Metabolism—ST3GAL2—kidney cancer	2.97e-06	0.000802	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	2.95e-06	0.000798	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—ITPR2—kidney cancer	2.92e-06	0.000789	CbGpPWpGaD
Alfentanil—ALB—Metabolism—ALDH1A1—kidney cancer	2.9e-06	0.000784	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	2.88e-06	0.00078	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ACY1—kidney cancer	2.86e-06	0.000773	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—IGF2—kidney cancer	2.84e-06	0.000767	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GPC3—kidney cancer	2.81e-06	0.00076	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PGK1—kidney cancer	2.78e-06	0.000752	CbGpPWpGaD
Alfentanil—ALB—Metabolism—SLC5A3—kidney cancer	2.78e-06	0.000752	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CA9—kidney cancer	2.75e-06	0.000742	CbGpPWpGaD
Alfentanil—ABCB1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	2.74e-06	0.000742	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—GSTT1—kidney cancer	2.74e-06	0.00074	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—ACHE—kidney cancer	2.74e-06	0.00074	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CA2—kidney cancer	2.73e-06	0.000739	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	2.73e-06	0.000739	CbGpPWpGaD
Alfentanil—ALB—Metabolism—LDHB—kidney cancer	2.73e-06	0.000737	CbGpPWpGaD
Alfentanil—ALB—Platelet activation, signaling and aggregation—IL2—kidney cancer	2.72e-06	0.000734	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ALAD—kidney cancer	2.66e-06	0.00072	CbGpPWpGaD
Alfentanil—ABCB1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	2.65e-06	0.000717	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CTNNA1—kidney cancer	2.65e-06	0.000716	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—HSPB1—kidney cancer	2.63e-06	0.000712	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—EIF4EBP1—kidney cancer	2.63e-06	0.000712	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	2.61e-06	0.000705	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ST3GAL2—kidney cancer	2.6e-06	0.000703	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	2.6e-06	0.000703	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—SCARB1—kidney cancer	2.59e-06	0.000701	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	2.58e-06	0.000698	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PTGS1—kidney cancer	2.57e-06	0.000694	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ALDH1A1—kidney cancer	2.54e-06	0.000687	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PSMD7—kidney cancer	2.52e-06	0.00068	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	2.52e-06	0.00068	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—TSC1—kidney cancer	2.45e-06	0.000661	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PSMD7—kidney cancer	2.45e-06	0.000661	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—ANXA1—kidney cancer	2.45e-06	0.000661	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PGK1—kidney cancer	2.44e-06	0.000659	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—SLC5A3—kidney cancer	2.44e-06	0.000659	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PDHB—kidney cancer	2.43e-06	0.000657	CbGpPWpGaD
Alfentanil—CYP3A4—Biological oxidations—POMC—kidney cancer	2.42e-06	0.000655	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—LDHB—kidney cancer	2.39e-06	0.000646	CbGpPWpGaD
Alfentanil—ALB—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.39e-06	0.000646	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—BCHE—kidney cancer	2.39e-06	0.000645	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—FLT1—kidney cancer	2.37e-06	0.000641	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CA9—kidney cancer	2.37e-06	0.000639	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—SLC5A5—kidney cancer	2.36e-06	0.000637	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CRABP1—kidney cancer	2.34e-06	0.000631	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.31e-06	0.000625	CbGpPWpGaD
Alfentanil—ALB—Platelet activation, signaling and aggregation—VEGFA—kidney cancer	2.31e-06	0.000624	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CCBL1—kidney cancer	2.29e-06	0.000618	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—SLC2A1—kidney cancer	2.28e-06	0.000615	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	2.27e-06	0.000614	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—POMC—kidney cancer	2.23e-06	0.000604	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PAK1—kidney cancer	2.2e-06	0.000594	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—JUNB—kidney cancer	2.2e-06	0.000594	CbGpPWpGaD
Alfentanil—ALB—Platelet activation, signaling and aggregation—MAPK3—kidney cancer	2.18e-06	0.00059	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—ITPR2—kidney cancer	2.17e-06	0.000587	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	2.15e-06	0.000581	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	2.09e-06	0.000565	CbGpPWpGaD
Alfentanil—ALB—Platelet activation, signaling and aggregation—MAPK1—kidney cancer	2.08e-06	0.000562	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CA9—kidney cancer	2.07e-06	0.00056	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	2.05e-06	0.000553	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—POMC—kidney cancer	2.03e-06	0.000549	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CRABP1—kidney cancer	2.01e-06	0.000544	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PPAT—kidney cancer	1.98e-06	0.000536	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.98e-06	0.000536	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—ACHE—kidney cancer	1.98e-06	0.000535	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—GSTT1—kidney cancer	1.98e-06	0.000535	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	1.93e-06	0.000522	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—GSTP1—kidney cancer	1.9e-06	0.000513	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—SCARB1—kidney cancer	1.87e-06	0.000507	CbGpPWpGaD
Alfentanil—ALB—Metabolism—ITPR2—kidney cancer	1.87e-06	0.000505	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PTGS1—kidney cancer	1.86e-06	0.000502	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—FH—kidney cancer	1.84e-06	0.000498	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—APRT—kidney cancer	1.84e-06	0.000498	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PSMD7—kidney cancer	1.82e-06	0.000492	CbGpPWpGaD
Alfentanil—ALB—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	1.8e-06	0.000487	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—ABCB1—kidney cancer	1.8e-06	0.000486	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—IGF2—kidney cancer	1.8e-06	0.000486	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CDKN2B—kidney cancer	1.79e-06	0.000483	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	1.77e-06	0.00048	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CRABP1—kidney cancer	1.76e-06	0.000476	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—GSTM1—kidney cancer	1.74e-06	0.000472	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—IGF1R—kidney cancer	1.74e-06	0.000469	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GPC3—kidney cancer	1.73e-06	0.000468	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—BCHE—kidney cancer	1.72e-06	0.000466	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.72e-06	0.000466	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	1.72e-06	0.000464	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GSTT1—kidney cancer	1.71e-06	0.000461	CbGpPWpGaD
Alfentanil—ALB—Metabolism—ACHE—kidney cancer	1.71e-06	0.000461	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—SLC5A5—kidney cancer	1.7e-06	0.000461	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CA2—kidney cancer	1.68e-06	0.000455	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—RAF1—kidney cancer	1.67e-06	0.000452	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—CYP1A1—kidney cancer	1.65e-06	0.000447	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—IL2—kidney cancer	1.65e-06	0.000447	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—SLC2A1—kidney cancer	1.65e-06	0.000445	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ALAD—kidney cancer	1.64e-06	0.000444	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ITPR2—kidney cancer	1.64e-06	0.000443	CbGpPWpGaD
Alfentanil—ALB—Metabolism—SCARB1—kidney cancer	1.61e-06	0.000436	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.6e-06	0.000433	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PTGS1—kidney cancer	1.6e-06	0.000432	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PSMD7—kidney cancer	1.57e-06	0.000424	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.57e-06	0.000423	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—RAF1—kidney cancer	1.56e-06	0.000422	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PGK1—kidney cancer	1.5e-06	0.000406	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.5e-06	0.000406	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—IL2—kidney cancer	1.5e-06	0.000406	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GSTT1—kidney cancer	1.49e-06	0.000404	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ACHE—kidney cancer	1.49e-06	0.000404	CbGpPWpGaD
Alfentanil—ALB—Metabolism—BCHE—kidney cancer	1.49e-06	0.000402	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—LDHB—kidney cancer	1.47e-06	0.000398	CbGpPWpGaD
Alfentanil—ALB—Metabolism—SLC5A5—kidney cancer	1.47e-06	0.000397	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—HIF1A—kidney cancer	1.43e-06	0.000386	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—TSC2—kidney cancer	1.43e-06	0.000385	CbGpPWpGaD
Alfentanil—ALB—Metabolism—SLC2A1—kidney cancer	1.42e-06	0.000383	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—SCARB1—kidney cancer	1.41e-06	0.000382	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PTGS1—kidney cancer	1.4e-06	0.000378	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—IL2—kidney cancer	1.4e-06	0.000378	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.37e-06	0.000372	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PSMD7—kidney cancer	1.37e-06	0.000371	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—GSTP1—kidney cancer	1.37e-06	0.000371	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—KDR—kidney cancer	1.37e-06	0.00037	CbGpPWpGaD
Alfentanil—ALB—Transmembrane transport of small molecules—RAF1—kidney cancer	1.35e-06	0.000365	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—BCHE—kidney cancer	1.3e-06	0.000352	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—ABCB1—kidney cancer	1.3e-06	0.000351	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—SLC5A5—kidney cancer	1.29e-06	0.000348	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CA9—kidney cancer	1.28e-06	0.000345	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—GSTM1—kidney cancer	1.26e-06	0.000341	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—APC—kidney cancer	1.26e-06	0.00034	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—KIT—kidney cancer	1.26e-06	0.00034	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—SLC2A1—kidney cancer	1.24e-06	0.000336	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—POMC—kidney cancer	1.23e-06	0.000333	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—MAPK3—kidney cancer	1.21e-06	0.000326	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.2e-06	0.000324	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—POMC—kidney cancer	1.2e-06	0.000324	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CYP1A1—kidney cancer	1.2e-06	0.000323	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—VEGFA—kidney cancer	1.19e-06	0.000322	CbGpPWpGaD
Alfentanil—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	1.18e-06	0.00032	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—BRAF—kidney cancer	1.18e-06	0.00032	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GSTP1—kidney cancer	1.18e-06	0.000319	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—MAPK1—kidney cancer	1.15e-06	0.00031	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—MAPK3—kidney cancer	1.13e-06	0.000304	CbGpPWpGaD
Alfentanil—ALB—Metabolism—ABCB1—kidney cancer	1.12e-06	0.000302	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—PIK3CA—kidney cancer	1.1e-06	0.000296	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GSTM1—kidney cancer	1.09e-06	0.000294	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CRABP1—kidney cancer	1.09e-06	0.000293	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—KRAS—kidney cancer	1.08e-06	0.000293	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—MAPK1—kidney cancer	1.07e-06	0.000289	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GSTP1—kidney cancer	1.04e-06	0.00028	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CYP1A1—kidney cancer	1.03e-06	0.000278	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—KRAS—kidney cancer	1.01e-06	0.000273	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ITPR2—kidney cancer	1.01e-06	0.000273	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—PIK3CA—kidney cancer	9.96e-07	0.000269	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—RAF1—kidney cancer	9.88e-07	0.000267	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—RELA—kidney cancer	9.84e-07	0.000266	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PTGS2—kidney cancer	9.84e-07	0.000266	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—ERBB2—kidney cancer	9.78e-07	0.000264	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—MTOR—kidney cancer	9.65e-07	0.000261	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GSTM1—kidney cancer	9.52e-07	0.000257	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—PIK3CA—kidney cancer	9.29e-07	0.000251	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ACHE—kidney cancer	9.2e-07	0.000249	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GSTT1—kidney cancer	9.2e-07	0.000249	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CDKN1B—kidney cancer	9.06e-07	0.000245	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CYP1A1—kidney cancer	9.02e-07	0.000244	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—TP53—kidney cancer	8.99e-07	0.000243	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—POMC—kidney cancer	8.91e-07	0.000241	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—IL2—kidney cancer	8.86e-07	0.00024	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—SCARB1—kidney cancer	8.71e-07	0.000236	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CCND1—kidney cancer	8.64e-07	0.000234	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PTGS1—kidney cancer	8.62e-07	0.000233	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—JUN—kidney cancer	8.62e-07	0.000233	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PTEN—kidney cancer	8.58e-07	0.000232	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CTNNB1—kidney cancer	8.56e-07	0.000231	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	8.46e-07	0.000229	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PSMD7—kidney cancer	8.46e-07	0.000229	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PTEN—kidney cancer	8.34e-07	0.000225	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—BCHE—kidney cancer	8.02e-07	0.000217	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—SLC5A5—kidney cancer	7.92e-07	0.000214	CbGpPWpGaD
Alfentanil—ALB—Metabolism—POMC—kidney cancer	7.68e-07	0.000208	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—SLC2A1—kidney cancer	7.65e-07	0.000207	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—VEGFA—kidney cancer	7.53e-07	0.000204	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—MAPK3—kidney cancer	7.13e-07	0.000193	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PTGS2—kidney cancer	7.11e-07	0.000192	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—MYC—kidney cancer	6.93e-07	0.000187	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—MAPK1—kidney cancer	6.78e-07	0.000183	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—POMC—kidney cancer	6.73e-07	0.000182	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—KRAS—kidney cancer	6.4e-07	0.000173	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GSTP1—kidney cancer	6.38e-07	0.000172	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PTEN—kidney cancer	6.2e-07	0.000168	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PTGS2—kidney cancer	6.12e-07	0.000166	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PIK3CA—kidney cancer	6.05e-07	0.000164	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ABCB1—kidney cancer	6.04e-07	0.000163	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PIK3CA—kidney cancer	5.88e-07	0.000159	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GSTM1—kidney cancer	5.86e-07	0.000158	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—TP53—kidney cancer	5.69e-07	0.000154	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CYP1A1—kidney cancer	5.56e-07	0.00015	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PTGS2—kidney cancer	5.36e-07	0.000145	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PTEN—kidney cancer	5.34e-07	0.000144	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PTEN—kidney cancer	4.68e-07	0.000126	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PIK3CA—kidney cancer	4.37e-07	0.000118	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—POMC—kidney cancer	4.14e-07	0.000112	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PIK3CA—kidney cancer	3.77e-07	0.000102	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PTGS2—kidney cancer	3.31e-07	8.93e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PIK3CA—kidney cancer	3.3e-07	8.92e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PTEN—kidney cancer	2.88e-07	7.79e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PIK3CA—kidney cancer	2.03e-07	5.5e-05	CbGpPWpGaD
